Advertisement
| us pharmaceutical industry porter's 5 forces analysis: Competitive Strategy Michael E. Porter, 1998 In this pathbreaking book, Michael E. Porter unravels the rules that govern competition and turns them into powerful analytical tools to help management interpret market signals and forecast the direction of industry development. |
| us pharmaceutical industry porter's 5 forces analysis: Leading Pharmaceutical Innovation Oliver Gassmann, Gerrit Reepmeyer, Maximilian von Zedtwitz, 2013-06-05 Pharmaceutical innovation is like gambling at roulette, only the stakes are higher. Considerably higher, since the most recent estimates put the costs of drug development at US$ 800 million to US$ 1 billion - per drug! This is equivalent to the price tag of the Empire State Building, when it was for sale a few years ago. In 2001, the major US and European pharmaceutical companies invested more than US$ 30 billion in R&D, at a higher R&D to-sales ratio than virtually any other industry, including chemicals, auto mobiles, electronics, aerospace, and computers. Delivering a blockbuster drug is the Holy Grail for any pharmaceutical company. But in the last decade the rules of developing blockbusters seem to have changed. On the one hand, more sophisticated screening technolo gies, genetic engineering, and expanding networks with biotechnology companies increase the probability of commercial success. Critical success factors include the discovery phase and a stronger outside-in orientation in the early innovation phase. After the implosion of the high-tech stock mar ket, biotechnology and other technology-driven opportunities may have lost some of their attractiveness for big pharma: a pipeline of solid and predictable innovations seems to be the highest goal of most pharmaceuti cal companies again. On the other hand, despite significant investments in pipeline management and novel technologies, there is still no recipe for ensuring a blockbuster hit. |
| us pharmaceutical industry porter's 5 forces analysis: The Palgrave Encyclopedia of Strategic Management , 2018-05-04 The Palgrave Encyclopedia of Strategic Management has been written by an international team of leading academics, practitioners and rising stars and contains almost 550 individually commissioned entries. It is the first resource of its kind to pull together such a comprehensive overview of the field and covers both the theoretical and more empirically/practitioner oriented side of the discipline. |
| us pharmaceutical industry porter's 5 forces analysis: The U.S. Tobacco Industry Verner N. Grise, 1988 |
| us pharmaceutical industry porter's 5 forces analysis: Strategic Marketing Issues in Emerging Markets Atanu Adhikari, 2018-07-27 This book presents a collection of articles addressing a range of marketing strategies unique to emerging economies. It describes the component of strategic and tactical marketing, including the marketing mix, segments and targeting, product and market orientation, employing the Internet and social media, penetration and loyalty strategies and innovation, and other strategy issues in the marketing context. In addition, the book focuses on creating, communicating, and delivering customer value to emerging market consumers through diverse marketing strategies, processes, and programs in the context of emerging markets’ dynamics, consumer diversity, and competitors. Bringing together contributors from industry and academia to explore key marketing issues prevalent in India and other emerging economies, the book offers a unique and insightful read for a global audience. This book, edited by Dr. Atanu Adhikari, offers important analytical and managerial insights into consumer behavior, firm strategy, market dynamics and marketing instruments (price, promotion, distribution and product). While marketing and management disciplines have developed useful empirical generalizations, the context is critical. This book does exactly that -- place the generalized results in the context of emerging markets and India. Accordingly, this is a valuable resource for scholars and practitioners. -- Dr. Gurumurthy Kalyanaram, Professor, City University of New York, USA and Tata Institute of Social Sciences, Mumbai, India; US Editor, International Journal of Learning and Change; and President, MIT South Asian Alumni Association This book is a must-read for anyone interested in marketing to less-developed countries. While the focus of the chapters is on India, the lessons learned can be generally applied. The 32 chapters represent comprehensive coverage of nearly every topic related to marketing with many examples. Any manager interested in doing business in emerging markets, Professors who want a better knowledge of these markets, or students who want an excellent reference should acquire this book. -- Dr. Russell S. Winer, William Joyce Professor of Marketing, Stern School of Business, New York University, USA. |
| us pharmaceutical industry porter's 5 forces analysis: Understanding Michael Porter Joan Magretta, 2012 A guide to Michael Porters thinking on competition and strategy, classic and current. |
| us pharmaceutical industry porter's 5 forces analysis: Marketing Planning for the Pharmaceutical Industry John Lidstone, Janice MacLennan, 2017-07-05 Marketing in the pharmaceutical and healthcare sector requires a particular set of skills; its intricacies mean planning is an essential prerequisite. The marketing planning system described in this book has been designed to enable marketing and product executives to produce a plan which serves as a dynamic management tool which will help them to get from where they are now to where they want to be next year and thereafter. Now in its second edition, this bestselling book has become the standard text for all product managers, marketing managers and directors working in this demanding industry. John Lidstone and Janice MacLennan have updated the book to embrace best current practice. A new orientation to external analysis and a reworking of the application of SWOT analysis, along with fresh material on sales forecasting and strategy implementation, bring the book up to date with current thinking and industry trends. Marketing Planning for the Pharmaceutical Industry is based on real life experience built up over many years. Each chapter takes the reader through the sequential stages of planning so that by the end they will be able to produce a practical plan ready for implementation. It is the only book of this type which tailors marketing to those working in the sector and as such is a unique, invaluable and indispensable resource. |
| us pharmaceutical industry porter's 5 forces analysis: Corporate Crime in the Pharmaceutical Industry (Routledge Revivals) John Braithwaite, 2013-10-08 First published in 1984, this book examines corporate crime in the pharmaceutical industry. Based on extensive research, including interviews with 131 senior executives of pharmaceutical companies in the United States, the United Kingdom, Australia, Mexico and Guatemala, the book is a major study of white-collar crime. Written in the 1980s, it covers topics such as international bribery and corruption, fraud in the testing of drugs and criminal negligence in the unsafe manufacturing of drugs. The author considers the implications of his findings for a range of strategies to control corporate crime, nationally and internationally. |
| us pharmaceutical industry porter's 5 forces analysis: Proceedings of the 2022 6th International Seminar on Education, Management and Social Sciences (ISEMSS 2022) Ghaffar Ali, Mehmet Cüneyt Birkök, Intakhab Alam Khan, 2023-09-16 This is an open access book. The aim of 2022 6th International Seminar on Education, Management and Social Sciences (ISEMSS 2022) is to bring together innovative academics and industrial experts in the field of Education, Management and Social Sciences to a common forum. The primary goal of the conference is to promote research and developmental activities in Education, Management and Social Sciences and another goal is to promote scientific information interchange between researchers, developers, students, and practitioners working all around the world. The conference will be held every year to make it an ideal platform for people to share views and experiences in Education, Management and Social Sciences and related areas. |
| us pharmaceutical industry porter's 5 forces analysis: Strategy David Faulkner, 2002 This is the most comprehensive collection to date on all aspects of strategy. The articles selected here discuss key themes, including:* different conceptions of strategy, such as the classical, rational models of Porter, the empirical, emergent emphasis of Mintzberg, and the competence based models of Grant and others * the relationship between strategy and other subjects including economics and organizational studies * scenario planning, networks, strategic groups and knowledge, and other key new developments * the implications of globalization and international management * key strategic decisions including diversification and mergers and acquisitionsWith a new introduction by the editor and an extensive index, this collection is an invaluable reference tool and teaching aid. |
| us pharmaceutical industry porter's 5 forces analysis: The Politics Industry Katherine M. Gehl, Michael E. Porter, 2020-06-23 Leading political innovation activist Katherine Gehl and world-renowned business strategist Michael Porter bring fresh perspective, deep scholarship, and a real and actionable solution, Final Five Voting, to the grand challenge of our broken political and democratic system. Final Five Voting has already been adopted in Alaska and is being advanced in states across the country. The truth is, the American political system is working exactly how it is designed to work, and it isn't designed or optimized today to work for us—for ordinary citizens. Most people believe that our political system is a public institution with high-minded principles and impartial rules derived from the Constitution. In reality, it has become a private industry dominated by a textbook duopoly—the Democrats and the Republicans—and plagued and perverted by unhealthy competition between the players. Tragically, it has therefore become incapable of delivering solutions to America's key economic and social challenges. In fact, there's virtually no connection between our political leaders solving problems and getting reelected. In The Politics Industry, business leader and path-breaking political innovator Katherine Gehl and world-renowned business strategist Michael Porter take a radical new approach. They ingeniously apply the tools of business analysis—and Porter's distinctive Five Forces framework—to show how the political system functions just as every other competitive industry does, and how the duopoly has led to the devastating outcomes we see today. Using this competition lens, Gehl and Porter identify the most powerful lever for change—a strategy comprised of a clear set of choices in two key areas: how our elections work and how we make our laws. Their bracing assessment and practical recommendations cut through the endless debate about various proposed fixes, such as term limits and campaign finance reform. The result: true political innovation. The Politics Industry is an original and completely nonpartisan guide that will open your eyes to the true dynamics and profound challenges of the American political system and provide real solutions for reshaping the system for the benefit of all. THE INSTITUTE FOR POLITICAL INNOVATION The authors will donate all royalties from the sale of this book to the Institute for Political Innovation. |
| us pharmaceutical industry porter's 5 forces analysis: The Strategic Marketing of Science, Technology, and Medical Journals Albert N. Greco, 2023-06-30 This book analyzes the various economic and marketing strategies utilized by the five major STM commercial scholarly journal publishers since 2000. This period has witnessed tremendous economic, marketing, and technological growth including the migration from a print only to a hybrid publishing format. With this growth, the industry has also seen the rise of open access publishing, copyright challenges by websites such as Sci-Hub, the emergence of sharing platforms such as ResearchGate and Academia.edu, as well as the impact of Plan S on publishers, universities, and authors. Given this incredible rate of change across the industry, the author explores the diverse strategies and structures created by the largest STm publishers to decipher their effectiveness in addressing technological, ethical, and copyright issues. Also, he examines how mergers and acquisitions diversified operations, such Elsevier's acquisition of Bepress, SSRN, and SCOPUS, among other platforms. Scrutinizing the different managerial, marketing, technology, and economic-financial strategies crafted by scholarly journal publishers between 2000-2020, this book offers a comprehensive assessment of the industry's attempts to identify, understand, cope with, and minimize or defeat the herculean threats to its business model. |
| us pharmaceutical industry porter's 5 forces analysis: U.S. Army Medical Department Journal , 2010 |
| us pharmaceutical industry porter's 5 forces analysis: The Competitive Strategy Michael E. Porter, 2003-12-26 Now nearing its 60th printing in English and translated into nineteen languages, Michael E. Porter's Competitive Strategy has transformed the theory, practice, and teaching of business strategy throughout the world. Electrifying in its simplicity -- like all great breakthroughs -- Porter's analysis of industries captures the complexity of industry competition in five underlying forces. Porter introduces one of the most powerful competitive tools yet developed: his three generic strategies -- lowest cost, differentiation, and focus -- which bring structure to the task of strategic positioning. He shows how competitive advantage can be defined in terms of relative cost and relative prices, thus linking it directly to profitability, and presents a whole new perspective on how profit is created and divided. In the almost two decades since publication, Porter's framework for predicting competitor behavior has transformed the way in which companies look at their rivals and has given rise to the new discipline of competitor assessment. More than a million managers in both large and small companies, investment analysts, consultants, students, and scholars throughout the world have internalized Porter's ideas and applied them to assess industries, understand competitors,, and choose competitive positions. The ideas in the book address the underlying fundamentals of competition in a way that is independent of the specifics of the ways companies go about competing. Competitive Strategy has filled a void in management thinking. It provides an enduring foundation and grounding point on which all subsequent work can be built. By bringing a disciplined structure to the question of how firms achieve superior profitability, Porter's rich frameworks and deep insights comprise a sophisticated view of competition unsurpassed in the last quarter-century. |
| us pharmaceutical industry porter's 5 forces analysis: Porter's Five Forces 50MINUTES.COM., 2015 |
| us pharmaceutical industry porter's 5 forces analysis: Pharmaceutical Marketing Eugene Mick Kolassa, James Greg Perkins, Bruce R Siecker, 2002-03-12 Explore the nuts and bolts of marketing pharmaceuticals today! Written by leading authorities in the field, Pharmaceutical Marketing: Principles, Environment, and Practice is the fifth in Dr. Mickey Smith's series of books on the subject which began in the 1960s. In this extraordinary book, he and his co-authors examine the principles of marketing pharmaceuticals, describe the environmental factors that affect their application, and show how these principles can be applied in response to those factors in practice. From the history and development of marketing pharmaceuticals to channel systems, legal requirements, budgeting, and product placement, this essential volume is a comprehensive text that will help students prepare for successful careers in this expanding field. From editor Mickey Smith: “Looking back on 40 years of experience, I’ve recently begun saying that most of the things I knew about pharmaceutical marketing over the years that made me so smart are not true anymore. But the fact is that the principles of marketing are as true as they were when they appeared in my first book (published in 1968). What has changed, and had to change, was the way the principles are applied. “This book is based on the premise that marketing follows certain principles and that pharmaceutical marketing is affected by a variety of environmental influences which lead to a rich array of marketing practices. These practices are presented to demonstrate how the successful application of marketing principles—with appropriate adaptation to environmental forces—can lead to success in the marketplace. Failures are also presented.” This well-referenced book explores and explains the principles and practical application of vital elements of pharmaceutical marketing, including: product pricing—with sections on trends, competition, reimbursement programs, public policy, and more research and development—including strategies relating to new products, product scope, positioning and repositioning, product elimination, diversification, and a fascinating case study about Ibuprofen promotion—rational and nonrational appeals, advertising prescription drugs to consumers, strategic choices among media types, budgeting, and more place factors, channel systems, physical distribution, and specialists and much more! Ideal for anyone entering or studying the pharmaceutical industry, Pharmaceutical Marketing: Principles, Environment, and Practice is a one-stop source of reliable knowledge that you’ll refer to again and again! In the editor's words, “Good marketing leads to good medicine. Exceptions exist, but when the system works, bad marketing never succeeds for long—and neither does bad medicine.” |
| us pharmaceutical industry porter's 5 forces analysis: Competitive Advantage Michael E. Porter, 2008-06-30 Now beyond its eleventh printing and translated into twelve languages, Michael Porter’s The Competitive Advantage of Nations has changed completely our conception of how prosperity is created and sustained in the modern global economy. Porter’s groundbreaking study of international competitiveness has shaped national policy in countries around the world. It has also transformed thinking and action in states, cities, companies, and even entire regions such as Central America. Based on research in ten leading trading nations, The Competitive Advantage of Nations offers the first theory of competitiveness based on the causes of the productivity with which companies compete. Porter shows how traditional comparative advantages such as natural resources and pools of labor have been superseded as sources of prosperity, and how broad macroeconomic accounts of competitiveness are insufficient. The book introduces Porter’s “diamond,” a whole new way to understand the competitive position of a nation (or other locations) in global competition that is now an integral part of international business thinking. Porter's concept of “clusters,” or groups of interconnected firms, suppliers, related industries, and institutions that arise in particular locations, has become a new way for companies and governments to think about economies, assess the competitive advantage of locations, and set public policy. Even before publication of the book, Porter’s theory had guided national reassessments in New Zealand and elsewhere. His ideas and personal involvement have shaped strategy in countries as diverse as the Netherlands, Portugal, Taiwan, Costa Rica, and India, and regions such as Massachusetts, California, and the Basque country. Hundreds of cluster initiatives have flourished throughout the world. In an era of intensifying global competition, this pathbreaking book on the new wealth of nations has become the standard by which all future work must be measured. |
| us pharmaceutical industry porter's 5 forces analysis: Valuation of Grifols Muhammad Chaudhary, Azeem, Llano Sánchez, Íñigo, 2021-06-17 The purpose of this dissertation is to determine the intrinsic value of Grifols, a leading pharmaceutical company that manufactures plasma-derived medicines. The authors have conducted a fundamental analysis of Grifols by examining the macro and microeconomic factors that affect the environment it operates in, the competitive landscape, the corporate strategy, and the annual accounts of the company. Subsequently, they built their discounted cash flow (DCF) valuation model in Excel to calculate the intrinsic value of Grifols. They found that Grifols’ strong financial performance and its privileged access to sources of finance allows it to sustainably grow faster than competitors. Their results indicate that Grifols has an intrinsic value of €28.33 per share, which is higher than the current market value of €27.92 per share. The authors discover that Grifols’ economic moat will widen due to its collaboration with the U.S. government in the wake of COVID-19 and particularly due to its strategic initiative to expand to China. The already robust financial position is on track for sustained growth. Therefore, they firmly conclude that it is considered undervalued. The authors unanimously recommend potential investors to buy Grifols’ shares. |
| us pharmaceutical industry porter's 5 forces analysis: Pfizer and the Challenges of the Global Pharmaceutical Industry Axel Jörn, 2016-02-05 This Case Study defines the global pharmaceutical industry and its „boundaries“, analyses the profitability/attractiveness of the global pharmaceutical industry by using M.E.Porters’ Five-Forces-Model and answers the questions what overall industry trends can be identified and how the profitability/attractiveness of the industry will change in the future. Furthermore it explains and evaluates Pfizer’s new strategy and examines what Pfizer did in the recent years to maintain their profitability. |
| us pharmaceutical industry porter's 5 forces analysis: SWOT analysis , 2008 |
| us pharmaceutical industry porter's 5 forces analysis: Patent-term Extension and the Pharmaceutical Industry , 1981 |
| us pharmaceutical industry porter's 5 forces analysis: Congressional Record United States. Congress, 1977 The Congressional Record is the official record of the proceedings and debates of the United States Congress. It is published daily when Congress is in session. The Congressional Record began publication in 1873. Debates for sessions prior to 1873 are recorded in The Debates and Proceedings in the Congress of the United States (1789-1824), the Register of Debates in Congress (1824-1837), and the Congressional Globe (1833-1873) |
| us pharmaceutical industry porter's 5 forces analysis: Lords of Strategy Walter Kiechel, 2010-03-03 Imagine, if you can, the world of business - without corporate strategy. Remarkably, fifty years ago that's the way it was. Businesses made plans, certainly, but without understanding the underlying dynamics of competition, costs, and customers. It was like trying to design a large-scale engineering project without knowing the laws of physics. But in the 1960s, four mavericks and their posses instigated a profound shift in thinking that turbocharged business as never before, with implications far beyond what even they imagined. In The Lords of Strategy, renowned business journalist and editor Walter Kiechel tells, for the first time, the story of the four men who invented corporate strategy as we know it and set in motion the modern, multibillion-dollar consulting industry: Bruce Henderson, founder of Boston Consulting Group Bill Bain, creator of Bain & Company Fred Gluck, longtime Managing Director of McKinsey & Company Michael Porter, Harvard Business School professor Providing a window into how to think about strategy today, Kiechel tells their story with novelistic flair. At times inspiring, at times nearly terrifying, this book is a revealing account of how these iconoclasts and the organizations they led revolutionized the way we think about business, changed the very soul of the corporation, and transformed the way we work. |
| us pharmaceutical industry porter's 5 forces analysis: Communities in Action National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on Community-Based Solutions to Promote Health Equity in the United States, 2017-03-27 In the United States, some populations suffer from far greater disparities in health than others. Those disparities are caused not only by fundamental differences in health status across segments of the population, but also because of inequities in factors that impact health status, so-called determinants of health. Only part of an individual's health status depends on his or her behavior and choice; community-wide problems like poverty, unemployment, poor education, inadequate housing, poor public transportation, interpersonal violence, and decaying neighborhoods also contribute to health inequities, as well as the historic and ongoing interplay of structures, policies, and norms that shape lives. When these factors are not optimal in a community, it does not mean they are intractable: such inequities can be mitigated by social policies that can shape health in powerful ways. Communities in Action: Pathways to Health Equity seeks to delineate the causes of and the solutions to health inequities in the United States. This report focuses on what communities can do to promote health equity, what actions are needed by the many and varied stakeholders that are part of communities or support them, as well as the root causes and structural barriers that need to be overcome. |
| us pharmaceutical industry porter's 5 forces analysis: CRO – Contract Research Organization: How Drug Research is Evolving Jakob Miera, 2014-02-01 This book deals in general with mergers & acquisitions in the CRO industry, and more specifically with reasons for M&A, success factors during the M&A process, and why M&A can fail in the Contract Research Organization industry. The pharmaceutical industry faces increasing obstacles in respect to the development and introduction of new medications. That has to do with stricter requirements for admission and sharper controls by authorities. Today, the research and development of a new drug can easily consume more than $800 million and lasting between 10 and 15 years. Due to these facts pharmaceutical companies are looking for an alternative in the drug development process. A popular alternative is the outsourcing or in-house working with Contract Research Organizations (CRO). CRO are specialized in coordination and monitoring of drug development activities. The size of the CRO market in 2012 was around $32 billion and had an estimated market growth of around 9 – 12% for 2013. Increased outsourcing and allocation of R&D money towards CRO reflects a driving force for prospective growth. Contract Research Organizations consider mergers & acquisitions as a vital solution to achieve their objectives. |
| us pharmaceutical industry porter's 5 forces analysis: Pharmacy and the US Health Care System Michael Ira Smith, Albert I. Wertheimer, Jack E. Fincham, 2013 Pharmacy and the US Healthcare System is a one-stop textbook of current information about the features of the US healthcare system. It covers the personnel and institutions, along with concise reports on trends, regulations policy and finance. This new fourth edition has been updated with the most recent data, statistics and developments. It includes up-to-date information on many topics including financing, managed care pharmacy, political realities, and health information technology. There are new chapters on patient safety, pharmacovigilance, and ethics and professionalism. The healthcare field is evolving due to technological advances, pressure to increase efficiency and demand to increase costs. Pharmacy and the US Healthcare System prepares pharmacists for independent practice in this unpredictable environment. |
| us pharmaceutical industry porter's 5 forces analysis: Guide to the Healthcare Industry Karen L. Pellegrin, 2024-05-08 Healthcare′s advancements are undeniable, but delivering good value remains a challenge. Costs rise while quality improvements lag, leading some to call for removing business from healthcare entirely. This book offers a different perspective, inviting students and professionals to consider the potential of evidence-based business practices to improve healthcare and reduce costs. This engaging guide explores the unique complexities of the healthcare industry, highlighting why it′s ripe for disruption through innovative business solutions. By delving into how traditional models might not fit healthcare perfectly, the book paves the way for understanding how better business practices can unlock the potential for higher quality care at a lower cost. |
| us pharmaceutical industry porter's 5 forces analysis: Industrial Clusters in Biotechnology Vittorio Chiesa, Davide Chiaroni, 2005 The ultimate aim of Cleverbio has been to build a normative model that incorporates: |
| us pharmaceutical industry porter's 5 forces analysis: The SWOT Analysis 50minutes,, 2015-08-17 Develop strengths to decrease the weaknesses of your business This book is a practical and accessible guide to understanding and implementing the SWOT analysis, providing you with the essential information and saving time. In 50 minutes you will be able to: • Determine the strengths, weaknesses, opportunities and threats of your business • Distinguish the factors that affect the internal functioning and external environment of your business • Develop a coherent strategy ABOUT 50MINUTES.COM | Management & Marketing 50MINUTES.COM provides the tools to quickly understand the main theories and concepts that shape the economic world of today. Our publications are easy to use and they will save you time. They provide elements of theory and case studies, making them excellent guides to understand key concepts in just a few minutes. In fact, they are the starting point to take action and push your business to the next level. |
| us pharmaceutical industry porter's 5 forces analysis: The Pragmatic MBA for Scientific and Technical Executives Bertrand C. Liang, 2012-10-05 This primer enables professionals with technical expertise to collaborate with their business-side colleagues. Emphasizing brevity and clarity, it gives technical staff answers to their most pressing questions about economics, finance, marketing, strategic decision-making, accounting, management, and related subjects. It does not offer condensed 1st year MBA courses; instead, it presents streamlined concepts and insights that are easy enough to be accessible and challenging enough to hold one's interest. Its examples from pharma, IT, aircraft/navigation, and other industries highlight problems that technical professionals face daily. Written by one of them, its credibility makes it more useful than Internet resources. Because it concentrates on pragmatic (as opposed to academic) approaches to business, it empowers technical staff to stay with the conversation--and take it to a higher level.Bertrand C. Liang, MD, PhD, MBA, is Managing Director of LCC Ventures and Executive Director of Pfenex, Inc. He is trained in molecular biology and genetics (PhD) and is a clinician (MD) with subspecialty training in neurology and oncology, and serves as a Visiting University Professor at Liaoning He University, Shenyang, China. - Creates frameworks and builds concepts enabling technical staff to work with their business colleagues - Delivers content for pragmatic, immediate use, not condensed presentations of subjects from first year MBA curriculum - Extends readers' grasp by posting additional resources at a freely-available website |
| us pharmaceutical industry porter's 5 forces analysis: EPA Office of Compliance Sector Notebook Project , 1997 |
| us pharmaceutical industry porter's 5 forces analysis: Strategic Discovery Howard Thomas, Donald E. O'Neal, Raul Alvarado, 1998-02-04 Published in association with the Strategic Management Society, The Wiley Strategic Management Series aims to illustrate the best in global strategic management for academics, business practitioners and consultants. This book expands the understanding of strategic opportunities presented by the far reaching developments unfolding in the rapidly changing world economy, and in particular how they are impacting the North and South American continents. This wide-ranging collection of papers comprises a rich body of research and experience, spanning academics, business executives and consultants. Key emphasis is placed on competition and core competence, joint ventures and strategic alliances, and corporate performance. Writings included in this volume were selected as being representative of some of the most significant issues currently facing business strategists. |
| us pharmaceutical industry porter's 5 forces analysis: Countering the Problem of Falsified and Substandard Drugs Institute of Medicine, Board on Global Health, Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products, 2013-06-20 The adulteration and fraudulent manufacture of medicines is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treatment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country's drug supply, no single country can entirely guarantee this today. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense a counterfeit drug is one that infringes on a registered trademark. The lay meaning is much broader, including any drug made with intentional deceit. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate conflation of public health and intellectual property concerns. Countering the Problem of Falsified and Substandard Drugs accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be dealt with by courts, case by case, the report does not discuss the problem of counterfeit medicines. |
| us pharmaceutical industry porter's 5 forces analysis: The Oxford Handbook of Strategy David O. Faulkner, Andrew Campbell, 2006-04-06 Presents an analysis of how thinking on strategy has evolved and what are the likely developments. This work includes chapters on six key areas: Approaches to Strategy, Strategic Analysis and Formulation, Corporate Strategy; International Strategy; Strategies of Organizational Change; and Strategic Flexibility and Uncertainty. |
| us pharmaceutical industry porter's 5 forces analysis: Proceedings of the International Conference on Artificial Intelligence and Computer Vision (AICV2021) Aboul Ella Hassanien, Abdelkrim Haqiq, Peter J. Tonellato, Ladjel Bellatreche, Sam Goundar, Ahmad Taher Azar, Essaid Sabir, Driss Bouzidi, 2021-05-28 This book presents the 2nd International Conference on Artificial Intelligence and Computer Visions (AICV 2021) proceeding, which took place in Settat, Morocco, from June 28- to 30, 2021. AICV 2021 is organized by the Scientific Research Group in Egypt (SRGE) and the Computer, Networks, Mobility and Modeling Laboratory (IR2M), Hassan 1st University, Faculty of Sciences Techniques, Settat, Morocco. This international conference highlighted essential research and developments in the fields of artificial intelligence and computer visions. The book is divided into sections, covering the following topics: Deep Learning and Applications; Smart Grid, Internet of Things, and Mobil Applications; Machine Learning and Metaheuristics Optimization; Business Intelligence and Applications; Machine Vision, Robotics, and Speech Recognition; Advanced Machine Learning Technologies; Big Data, Digital Transformation, AI and Network Analysis; Cybersecurity; Feature Selection, Classification, and Applications. |
| us pharmaceutical industry porter's 5 forces analysis: Marketing Management Christie L. Nordhielm, Marta Dapena Baron, 2014-01-07 Marketing Management: The Big Picture organizes traditional Marketing Management theory and practice in a conceptually appealing way. The use of well-known examples and consumer commercials throughout the content ensures students will commit to memory and innovative method for structuring and solving marketing problems. The framework constitutes a disciplined approach to connecting marking variables to each other, inextricably linking marketing strategy concepts with their executional implications. |
| us pharmaceutical industry porter's 5 forces analysis: The Oxford Handbook of Strategy David Faulkner, Andrew Campbell, 2003-02-13 This two-volume handbook presents an authoritative and up-to-date analysis of how thinking on strategy has evolved and what are the likely developments in the near future. All the contributors are experts in their area, and bring to the topic an understanding informed by many years' experience of research, teaching, and practice. Volume One focuses on two major areas: first, the various different approaches to strategy, and secondly, the development of competitive or business unit strategy, where the pursuit of sustainable competitive advantage is the key objective. |
| us pharmaceutical industry porter's 5 forces analysis: Business and Competitive Analysis Craig S. Fleisher, Babette E. Bensoussan, 2015-01-12 Meet any business or competitive analysis challenge: deliver actionable business insights and on-point recommendations that enterprise decision makers can’t and won’t ignore! All you need is one book: Business and Competitive Analysis, Second Edition . This generation’s definitive guide to business and competitive analysis has now been thoroughly updated with additional methods, applications and examples. Craig S. Fleisher and Babette E. Bensoussan begin with a practical primer on the process and context of business and competitive analysis: how it works, how to avoid pitfalls, and how to communicate results. Next, they introduce their unique FAROUT method for choosing the right tools for each assignment. The authors then present dozens of today’s most valuable analysis methods. They cover “classic” techniques, such as McKinsey 7S and industry analysis, as well as emerging techniques from multiple disciplines: economics, corporate finance, sociology, anthropology, and the intelligence and futurist communities. You’ll find full chapters outlining effective analysis processes; avoiding pitfalls; communicating results; as well as drill-downs on analyzing industries, competitive positioning, business models, supply chains, strategic relationships, corporate reputation, critical success factors, driving forces, technology change, cash flow, and much more. For every method, Fleisher and Bensoussan present clear descriptions, background context, strategic rationales, strengths, weaknesses, step-by-step instructions, and references. The result is a book every analyst, strategist, and manager can rely on – in any industry, for any challenge. |
| us pharmaceutical industry porter's 5 forces analysis: Commercializing Successful Biomedical Technologies Shreefal S. Mehta, 2008-04-24 Successful product design and development requires the ability to take a concept and translate the technology into useful, patentable, commercial products. This book guides the reader through the practical aspects of the commercialization process of drug, diagnostic and device biomedical technology including market analysis, product development, intellectual property and regulatory constraints. Key issues are highlighted at each stage in the process, and case studies are used to provide practical examples. The book will provide a sound road map for those involved in the biotechnology industry to effectively plan the commercialization of profitable regulated medical products. It will also be suitable for a capstone design course in engineering and biotechnology, providing the student with the business acumen skills involved in product development. |
| us pharmaceutical industry porter's 5 forces analysis: Project Management for the Pharmaceutical Industry Mr Tony Grundy, Ms Laura Brown, 2012-09-28 The pharmaceutical industry has encountered major shifts in recent years, both within the industry, and in its external environment. The cost of healthcare rising due to an ageing population, the intensification of regulatory requirements and mergers within the industry have led to an increased need for restructuring, cost reduction and culture change projects. Project management is the key to addressing these needs, and also to effective drug development. Given the costs of development and the critical issue of 'time to market', project management techniques - appropriately used - are a key factor in bringing a drug to market. In this book, Laura Brown and Tony Grundy's pharmaceutical expertise and experience offers the reader a guide to the most relevant project management tools and techniques and how to rigorously apply them in the pharmaceutical industry. The authors cover the technical, strategic and human aspects of project management, including contingency planning, simulation techniques and different project options. Complete with decision-tree diagrams, checklists, exercises and a full glossary, Project Management for the Pharmaceutical Industry provides clinical research, drug development and quality assurance managers or directors with a one-stop reference for successfully managing pharmaceutical projects. The text has been revised for this edition and now includes some additional material on risk management. |
United States - Wikipedia
The United States of America (USA), also known as the United States (U.S.) or America, is a country primarily located in North America. It is a federal republic of 50 states and a federal …
U.S. Department of State – Home
Jun 10, 2025 · A .gov website belongs to an official government organization in the United States.
United States | History, Map, Flag, & Population | Britannica
2 days ago · Besides the 48 conterminous states that occupy the middle latitudes of the continent, the United States includes the state of Alaska, at the northwestern extreme of North America, …
Making government services easier to find | USAGov
Find out how to register to vote, where your voting location is, how presidential elections work, and more about voting in the United States.
U.S. News: Latest Breaking Stories, Video, and Photos on …
Get the latest news headlines and top stories from NBCNews.com. Find videos and news articles on the latest stories in the US.
United States - Simple English Wikipedia, the free encyclopedia
The United States of America, also known as the United States (U.S.) or simply America, is a sovereign country mostly in North America. It is divided into 50 states. 48 of these states and …
United States - The World Factbook
Jun 10, 2025 · The United States entry in The World Factbook provides a comprehensive overview of the country's geography, people, society, government, economy, and more.
USA TODAY - Breaking News and Latest News Today
See the top shots from the 2025 US Open at… See nationwide 'No Kings' protests amid Trump's… More in News in Pictures
United States Map - World Atlas
Jan 22, 2024 · The United States, officially known as the United States of America (USA), shares its borders with Canada to the north and Mexico to the south. To the east lies the vast Atlantic …
U.S. News | Latest National News, Videos & Photos - ABC News - ABC News
Jun 4, 2025 · US Border Patrol tactical unit deployed to help manhunt for escaped Arkansas inmate
United States - Wikipedia
The United States of America (USA), also known as the United States (U.S.) or America, is a country primarily located in North America. It is a federal republic of 50 states and a federal …
U.S. Department of State – Home
Jun 10, 2025 · A .gov website belongs to an official government organization in the United States.
United States | History, Map, Flag, & Population | Britannica
2 days ago · Besides the 48 conterminous states that occupy the middle latitudes of the continent, the United States includes the state of Alaska, at the northwestern extreme of North America, …
Making government services easier to find | USAGov
Find out how to register to vote, where your voting location is, how presidential elections work, and more about voting in the United States.
U.S. News: Latest Breaking Stories, Video, and Photos on …
Get the latest news headlines and top stories from NBCNews.com. Find videos and news articles on the latest stories in the US.
United States - Simple English Wikipedia, the free encyclopedia
The United States of America, also known as the United States (U.S.) or simply America, is a sovereign country mostly in North America. It is divided into 50 states. 48 of these states and …
United States - The World Factbook
Jun 10, 2025 · The United States entry in The World Factbook provides a comprehensive overview of the country's geography, people, society, government, economy, and more.
USA TODAY - Breaking News and Latest News Today
See the top shots from the 2025 US Open at… See nationwide 'No Kings' protests amid Trump's… More in News in Pictures
United States Map - World Atlas
Jan 22, 2024 · The United States, officially known as the United States of America (USA), shares its borders with Canada to the north and Mexico to the south. To the east lies the vast Atlantic …
U.S. News | Latest National News, Videos & Photos - ABC News - ABC News
Jun 4, 2025 · US Border Patrol tactical unit deployed to help manhunt for escaped Arkansas inmate
